Analystreport

Globus Medical Inc (NYSE: GMED) had its "buy" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $67.00 price target on the stock.

Globus Medical, Inc. Class A  (GMED) 
Last globus medical, inc. class a earnings: 2/20 04:15 pm Check Earnings Report
US:NYSE Investor Relations: investors.globusmedical.com